US 12,227,747 B2
Composition comprising aptamer as active ingredient for treatment and prevention of degenerative brain disease
In Sik Son, Seongnam-si (KR)
Assigned to NEXMOS Co., Ltd., Yongin-si (KR)
Appl. No. 17/292,710
Filed by Nexmos Co., LTD, Yongin-si (KR)
PCT Filed Oct. 11, 2019, PCT No. PCT/KR2019/013383
§ 371(c)(1), (2) Date May 10, 2021,
PCT Pub. No. WO2020/101181, PCT Pub. Date May 22, 2020.
Claims priority of application No. 10-2018-0140074 (KR), filed on Nov. 14, 2018; and application No. 10-2019-0055758 (KR), filed on May 13, 2019.
Prior Publication US 2022/0002729 A1, Jan. 6, 2022
Int. Cl. C12N 15/115 (2010.01); A61K 31/375 (2006.01); A61K 31/713 (2006.01); A61P 25/16 (2006.01)
CPC C12N 15/115 (2013.01) [A61K 31/375 (2013.01); A61K 31/713 (2013.01); A61P 25/16 (2018.01)] 5 Claims
 
1. A composition for the treatment and prevention of degenerative brain diseases comprising an aptamer consisting of the nucleotide sequence of SEQ ID: 1 and vitamin C.